Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New endoluminal technology: efficacy and safety--whose responsibility?

T Buckenham1

  • 1Department of Radiology, Christchurch Public Hospital, PB 4710, Christchurch, New Zealand. Timb@cdhb.govt.nz

Australasian Radiology
|September 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesenteric blood flow and muscle sympathetic nerve activity during vasovagal syncope.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2024
Same author

Association between metformin prescription and growth rates of abdominal aortic aneurysms.

The British journal of surgery·2017
Same author

Detection of Anomalous Cervical Internal Carotid Artery Branches by Colour Duplex Ultrasound.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
Same author

Outcomes of infected abdominal aortic grafts managed with antimicrobial therapy and graft retention in an unselected cohort.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2013
Same author

Management plan of post-angiography false aneurysms of the groin.

Annals of Saudi medicine·2007
Same author

Arterial compression of the right common iliac vein; an unusual anatomical variant.

Cardiovascular surgery (London, England)·2002
Same journal

Percutaneous biliary internal decompression in a patient with simultaneous malignant biliary and duodenal obstruction and surgically modified anatomy.

Australasian radiology·2008
Same journal

Fluoromethylcholine PET in recurrent multifocal hepatoma.

Australasian radiology·2008
Same journal

Patent urachus in a neonate: findings at micturating cystourethregram.

Australasian radiology·2008
Same journal

Combined treatment of ablative therapy with percutaneous radiofrequency and cementoplasty of a symptomatic metastatic lesion of the acetabulum.

Australasian radiology·2007
Same journal

Basilar artery aneurysm treated with coil embolization via persistent primitive hypoglossal artery.

Australasian radiology·2007
Same journal

Emergency embolization of multiple splenic artery pseudoaneurysms associated with portal hypertension complicating cystic fibrosis.

Australasian radiology·2007
See all related articles

Clinicians must collect and report long-term adverse event data for new endoluminal technologies used in arterial disease management. Robust data, not just clinical impressions, is crucial for evaluating these experimental devices.

Area of Science:

  • Vascular Surgery
  • Medical Device Technology
  • Clinical Trials

Background:

  • Endoluminal technologies are increasingly utilized for arterial disease management.
  • Experimental devices necessitate rigorous evaluation beyond initial feasibility studies.
  • The perceived advantages of some devices limit the feasibility of randomized controlled trials.

Purpose of the Study:

  • To discuss methods for assessing new endoluminal devices.
  • To define responsibilities for ongoing device evaluation.
  • To emphasize the need for robust data over clinical impressions.

Main Methods:

  • Review of current device assessment methodologies.
  • Analysis of post-market surveillance requirements.
  • Discussion of ethical and practical considerations in data collection.

Related Experiment Videos

Main Results:

  • Current assessment methods may be insufficient for long-term device evaluation.
  • Clear guidelines are needed for reporting adverse events.
  • Clinician responsibility in data collection is paramount.

Conclusions:

  • Ongoing, robust data collection is essential for endoluminal device safety and efficacy.
  • Standardized reporting of adverse events is critical.
  • A framework for continuous device evaluation must be established.